The UK Private GP EHR Market is expected to grow due to enhanced patient care needs and various regulations promoting secure storage of patient data. Technology advancements in healthcare and rising demand for private GP services contribute to this expansion. However, privacy concerns, security risks, and technical restraints could limit this growth. The report also reveals a significant increase in Google searches for private GPs in the UK, indicating heightened interest in private healthcare options.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
